Dr. Timos Papagatsias’ Post

Thoughts on this? >> FDA gives accelerated approval to PBC drug at the center of Gilead’s $4.3B CymaBay deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical

📢 Keeping patients' views and experiences front and centre is crucial. 📢 In May's edition of Pharmaceutical Market Europe, check out Joella's thoughts on how patient-centricity has evolved and how we need to continue pushing forward and make the experience of health conditions better for more people. 👏 Go to the PMGroup Worldwide Ltd site to read more! https://lnkd.in/e7gPmAVj #PME #patientcentricity

Several states are considering or have enacted legislation to create #prescriptiondrug affordability boards (PDABs), some of which have the authority to set upper payment limits (UPLs) on drugs. In a February 27 webinar, @Michael Kolber, @Jonathan DiBello and industry thought leaders will examine the current PDAB landscape, how UPLs might be implemented, and the ways UPLs could impact the #pharmaceutical supply chain. Learn more and register here: 

The ceiling price and its calculation fascinates me. And mostly because it’s been so secretive. Accountability and transparency are paramount in this program. And not just for covered entities.

Thoughts on this? >> Avadel's narcolepsy drug Lumryz misses PDUFA date, still under review at FDA >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical

Thoughts on this? >> Avadel's narcolepsy drug Lumryz misses PDUFA date, still under review at FDA >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #biotech #pharma

Discover the game-changing impact of the Inflation Reduction Act on the pharmaceutical industry. 🌟 Learn how it's reshaping drug pricing, fostering innovation, and expanding access to essential medications worldwide. 💊 #InflationReductionAct #PharmaRegulation #HealthcareCosts #DrugPricing #PharmaIndustry #Accessibility #Innovation #RegulatoryCompliance #PatientCare #PodcastDiscussion #HealthcarePolicy

Thoughts on this? >> CHMP recommends eight new drug approvals, six label expansions >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #pharmaceutical #healthcare #productmarketing

Thoughts on this? >> Steve Davis leaves Acadia, replaced by Bristol Myers alum; Former J&J exec to lead R&D at Novavax >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #healthcare #pharmaceutical

Great opportunity to get access to the experts in specialised commissioning and what the planned changes mean for your brands. It's also an opportunity to discuss your above brand strategy